Sangrix Inc. 修订 6-K/A 文件，变更特别股东大会提案一的股份合并比例

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K/A

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of October 2026

Commission File Number: 001-38857

SANGRIX INC.

160 Robinson Road, 12 F,

SBF Center, Singapore 068914

T: 347-556-4747

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F x    Form 40-F ¨

This Form 6-K/A amends the information furnished on Form 6-K by Sangrix Inc. (the “Company”) on October 23, 2026 (the “Original 6-K”) to change the share consolidation ratio in proposal one of the extraordinary general meeting. This Form 6-K/A does not otherwise amend, modify or update any information contained in the Original 6-K with respect to any events occurring after the furnishing of the Original 6-K. The amended and restated proxy statement and notice of extraordinary general meeting of shareholders and the amended and restated form of proxy card are filed as Exhibit 99.1 and 99.2, respectively to this Form 6-K/A. 

EXHIBIT INDEX

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

3